期刊文献+

糖尿病肾周脂肪细胞来源小细胞外囊泡促进肾小管上皮细胞上皮-间质转化

Diabetic perirenal adipocyte-derived small extracellular vesicles promote epithelial-mesenchymal transition in renal tubular epithelial cells
原文传递
导出
摘要 目的探讨糖尿病状态下肾周脂肪组织(PRAT)脂肪细胞来源小细胞外囊泡(sEVs)对肾小管上皮细胞的生物行为影响以及其分子机制。方法提取原代db/m、db/db小鼠PRAT脂肪细胞进行体外培养, 收集培养上清并通过超速离心法提取sEVs(NDM-sEVs^(PRAT-Adipo), DM-sEVs^(PRAT-Adipo))。将sEVs与人肾小管上皮细胞株(HK-2)细胞孵育, 观察其增殖、凋亡、自噬以及上皮-间质转化(EMT)水平。通过质谱技术分析sEVs蛋白成分, 探讨其作用的分子机制。结果 CCK8结果表明DM-sEVs^(PRAT-Adipo)干预后HK-2细胞的增殖水平与2个对照组(Ctrl组和NDM-sEVs^(PRAT-Adipo)干预组)相比无明显改变。Western印迹法结果表明, 对比2个对照组, DM-sEVs^(PRAT-Adipo)干预组的凋亡(Bcl-2、Cleaved-caspase 3、Caspase 3)和自噬(p62、LC3BⅠ、LC3BⅡ)水平无明显改变。Western印迹法和免疫荧光结果表明, 与2个对照组比较, DM-sEVs^(PRAT-Adipo)干预可上调HK-2的间质细胞标志蛋白(Vimentin、α-SMA、Snail2)表达水平, 下调上皮细胞标志蛋白ZO-1表达水平。sEVs质谱分析结果表明, DM-sEVs^(PRAT-Adipo)与NDM-sEVs^(PRAT-Adipo)的差异蛋白富集于EMT相关通路。其中, DM-sEVs^(PRAT-Adipo)富集血小板反应蛋白(THBS1), 该蛋白与EMT密切相关。结论糖尿病状态下, PRAT来源脂肪细胞分泌sEVs促进肾小管上皮细胞EMT上调, 此过程可能由sEVs中所富集的THBS1介导。 Objective:To investigate the impact of small extracellular vesicles(sEVs)derived from perirenal adipose cells on the biological behavior of renal tubular epithelial cells under diabetic conditions and the underlying molecular mechanisms.Methods:Primary perirenal adipose cells were extracted from db/m and db/db mice for in vitro culture.The culture supernatant was collected and sEVs(NDM-sEVs ^(PRAT-Adipo),DM-sEVs ^(PRAT-Adipo))were extracted by ultracentrifugation.The sEVs were incubated with human renal tubular epithelial cell line(HK-2)to observe changes in their proliferation,apoptosis,autophagy,and epithelial-mesenchymal transition(EMT)levels.The protein composition of sEVs was analyzed using mass spectrometry to explore the molecular mechanisms.Results:CCK8 results showed that the proliferation level of HK-2 cells after DM-sEVs ^(PRAT-Adipo) intervention did not change significantly compared with the two control groups(Ctrl group and NDM-sEVs ^(PRAT-Adipo) intervention group).Western Blot(WB)results indicated that there were no significant changes in apoptosis levels(Bcl-2,Cleaved-caspase 3,Caspase 3)and autophagy levels(p62,LC3BⅠ,LC3BⅡ)in the DM-sEVs ^(PRAT-Adipo) intervention group compared with the two control groups.WB and immunofluorescence results demonstrated that DM-sEVs ^(PRAT-Adipo) intervention upregulated the expression levels of mesenchymal cell marker proteins(Vimentin,α-SMA,Snail2)and downregulated the expression level of epithelial cell marker protein ZO-1 in HK-2 cells compared with the two control groups.Mass spectrometry analysis of sEVs revealed that the differential proteins between DM-sEVs ^(PRAT-Adipo) and NDM-sEVs ^(PRAT-Adipo) were enriched in EMT-related pathways.Among them,the enrichment of thrombospondin(THBS1)in DM-sEVs ^(PRAT-Adipo) might be involved in the regulation of EMT in HK-2 cells.Conclusion:Under diabetic conditions,sEVs secreted by PRAT-derived adipocytes promote the upregulation of EMT in renal tubular epithelial cells,a process that may be mediated by the enrichment of THBS1 in sEVs.
作者 余君言 林嘉彬 蔡雷琴 林江虹 洪晓思 杨于霖 任萌 孙侃 Yu Junyan;Lin Jiabin;Cai Leiqin;Lin Jianghong;Hong Xiaosi;Yang Yulin;Ren Meng;Sun Kan(Department of Endocrinology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China)
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2024年第7期586-593,共8页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金项目(81970696) 广东省自然科学基金项目(2019A1515011110,2022A1515012111)。
关键词 肾周脂肪组织 糖尿病肾病 小细胞外囊泡 肾小管上皮细胞 上皮-间质转化 Perirenal adipose tissue Diabetic kidney disease Small extracellular vesicles Renal tubular
  • 相关文献

参考文献2

二级参考文献26

  • 1Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012,379(9818):815-822.
  • 2Parving HH, Lewis JB, Ravid M, et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective[J]. Kidney Int, 2006,69(11):2057-2063.
  • 3Liu ZH. Nephrology in China[J]. Nat Rev Nephrol, 2013,9(9):523-528.
  • 4Woodward M, Patel A, Zoungas S, et al. Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trial[J]. Diabetes Care, 2011,34(12):2491-2495.
  • 5Zhuo L, Zou G, Li W, et al. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus[J]. Eur J Med Res, 2013,18:4.
  • 6KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease[J]. Am J Kidney Dis, 2007,49(2 Suppl 2):S12-S154.
  • 7American Diabetes Association. Standards of medical care in diabetes--2014[J]. Diabetes Care, 2014,37(Suppl 1):S14-S80.
  • 8KDOQI. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int Suppl, 2013,3(1):1-150.
  • 9Pedrinelli R, Dell′Omo G, Penno G, et al. Non-diabetic microalbu-minuria, endothelial dysfunction and cardiovascular disease[J]. Vasc Med, 2001,6(4):257-264.
  • 10Ekinci EI, Jerums G, Skene A, et al. Renal structure in normoalbumi-nuric and albuminuric patients with type 2 diabetes and impaired renal function[J]. Diabetes Care, 2013,36(11):3620-3626.

共引文献415

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部